nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunarizine—CALM1—type 2 diabetes mellitus	0.357	0.761	CbGaD
Flunarizine—CYP1A2—type 2 diabetes mellitus	0.112	0.239	CbGaD
Flunarizine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0504	0.135	CbGbCtD
Flunarizine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.026	0.0698	CbGbCtD
Flunarizine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0238	0.0638	CbGbCtD
Flunarizine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0221	0.0593	CbGbCtD
Flunarizine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0192	0.0517	CbGbCtD
Flunarizine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0188	0.0504	CbGbCtD
Flunarizine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0188	0.0504	CbGbCtD
Flunarizine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0173	0.0465	CbGbCtD
Flunarizine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0172	0.0461	CbGbCtD
Flunarizine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0167	0.0449	CbGbCtD
Flunarizine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0158	0.0426	CbGbCtD
Flunarizine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0153	0.0411	CbGbCtD
Flunarizine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0151	0.0407	CbGbCtD
Flunarizine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0143	0.0385	CbGbCtD
Flunarizine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0142	0.0382	CbGbCtD
Flunarizine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0136	0.0366	CbGbCtD
Flunarizine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.013	0.0349	CbGbCtD
Flunarizine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0125	0.0335	CbGbCtD
Flunarizine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00976	0.0262	CbGbCtD
Flunarizine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00961	0.0258	CbGbCtD
Flunarizine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00879	0.0236	CbGbCtD
Flunarizine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00344	0.0981	CbGeAlD
Flunarizine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.00231	0.0659	CbGeAlD
Flunarizine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.00167	0.0478	CbGeAlD
Flunarizine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.00167	0.0476	CbGeAlD
Flunarizine—CALM2—artery—type 2 diabetes mellitus	0.00132	0.0376	CbGeAlD
Flunarizine—CALM1—artery—type 2 diabetes mellitus	0.00131	0.0374	CbGeAlD
Flunarizine—CALM2—nerve—type 2 diabetes mellitus	0.00131	0.0373	CbGeAlD
Flunarizine—CALM1—nerve—type 2 diabetes mellitus	0.0013	0.0371	CbGeAlD
Flunarizine—CALM2—endothelium—type 2 diabetes mellitus	0.00111	0.0317	CbGeAlD
Flunarizine—CALM1—endothelium—type 2 diabetes mellitus	0.00111	0.0316	CbGeAlD
Flunarizine—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.000912	0.026	CbGeAlD
Flunarizine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000805	0.023	CbGeAlD
Flunarizine—CALM3—retina—type 2 diabetes mellitus	0.000688	0.0196	CbGeAlD
Flunarizine—CALM3—nephron tubule—type 2 diabetes mellitus	0.000648	0.0185	CbGeAlD
Flunarizine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000632	0.018	CbGeAlD
Flunarizine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000629	0.018	CbGeAlD
Flunarizine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000595	0.017	CbGeAlD
Flunarizine—CALM3—pancreas—type 2 diabetes mellitus	0.000566	0.0162	CbGeAlD
Flunarizine—CACNA1H—liver—type 2 diabetes mellitus	0.000564	0.0161	CbGeAlD
Flunarizine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000555	0.0158	CbGeAlD
Flunarizine—CALM2—retina—type 2 diabetes mellitus	0.000541	0.0154	CbGeAlD
Flunarizine—CALM1—retina—type 2 diabetes mellitus	0.000538	0.0154	CbGeAlD
Flunarizine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000513	0.0147	CbGeAlD
Flunarizine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000509	0.0145	CbGeAlD
Flunarizine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000507	0.0145	CbGeAlD
Flunarizine—Pimozide—CALM1—type 2 diabetes mellitus	0.000502	0.175	CrCbGaD
Flunarizine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000457	0.0131	CbGeAlD
Flunarizine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000455	0.013	CbGeAlD
Flunarizine—CALM2—kidney—type 2 diabetes mellitus	0.000447	0.0128	CbGeAlD
Flunarizine—CALM1—kidney—type 2 diabetes mellitus	0.000445	0.0127	CbGeAlD
Flunarizine—CALM2—pancreas—type 2 diabetes mellitus	0.000444	0.0127	CbGeAlD
Flunarizine—CALM1—pancreas—type 2 diabetes mellitus	0.000442	0.0126	CbGeAlD
Flunarizine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000436	0.0124	CbGeAlD
Flunarizine—Ezetimibe—ABCC2—type 2 diabetes mellitus	0.000435	0.152	CrCbGaD
Flunarizine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000434	0.0124	CbGeAlD
Flunarizine—CYP2A6—liver—type 2 diabetes mellitus	0.000418	0.0119	CbGeAlD
Flunarizine—CALM2—adipose tissue—type 2 diabetes mellitus	0.000403	0.0115	CbGeAlD
Flunarizine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000401	0.0115	CbGeAlD
Flunarizine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000378	0.0108	CbGeAlD
Flunarizine—CALM3—liver—type 2 diabetes mellitus	0.00036	0.0103	CbGeAlD
Flunarizine—CYP1A1—kidney—type 2 diabetes mellitus	0.000342	0.00977	CbGeAlD
Flunarizine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.00034	0.0097	CbGeAlD
Flunarizine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000337	0.00961	CbGeAlD
Flunarizine—CYP2B6—kidney—type 2 diabetes mellitus	0.000333	0.00949	CbGeAlD
Flunarizine—Meclizine—CYP1A2—type 2 diabetes mellitus	0.000318	0.111	CrCbGaD
Flunarizine—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000308	0.00881	CbGeAlD
Flunarizine—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000304	0.106	CrCbGaD
Flunarizine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000293	0.00836	CbGeAlD
Flunarizine—CALM2—liver—type 2 diabetes mellitus	0.000283	0.00807	CbGeAlD
Flunarizine—CALM1—liver—type 2 diabetes mellitus	0.000281	0.00803	CbGeAlD
Flunarizine—CYP2D6—kidney—type 2 diabetes mellitus	0.000247	0.00705	CbGeAlD
Flunarizine—Bifonazole—CYP2E1—type 2 diabetes mellitus	0.000224	0.0779	CrCbGaD
Flunarizine—CYP1A2—liver—type 2 diabetes mellitus	0.000219	0.00626	CbGeAlD
Flunarizine—CYP1A1—liver—type 2 diabetes mellitus	0.000216	0.00618	CbGeAlD
Flunarizine—CYP2B6—liver—type 2 diabetes mellitus	0.00021	0.006	CbGeAlD
Flunarizine—CYP2C9—liver—type 2 diabetes mellitus	0.000208	0.00594	CbGeAlD
Flunarizine—Ezetimibe—CYP3A4—type 2 diabetes mellitus	0.000192	0.067	CrCbGaD
Flunarizine—Astemizole—CYP3A4—type 2 diabetes mellitus	0.000192	0.067	CrCbGaD
Flunarizine—Pimozide—CYP2E1—type 2 diabetes mellitus	0.000166	0.0578	CrCbGaD
Flunarizine—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000158	0.055	CrCbGaD
Flunarizine—CYP2D6—liver—type 2 diabetes mellitus	0.000156	0.00446	CbGeAlD
Flunarizine—Bifonazole—CYP3A4—type 2 diabetes mellitus	0.000141	0.0491	CrCbGaD
Flunarizine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	0.000135	0.0471	CrCbGaD
Flunarizine—Pimozide—CYP3A4—type 2 diabetes mellitus	0.000105	0.0364	CrCbGaD
Flunarizine—CALM1—Disease—NOS3—type 2 diabetes mellitus	2.6e-06	2.17e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—NOS3—type 2 diabetes mellitus	2.6e-06	2.17e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—PIK3R1—type 2 diabetes mellitus	2.6e-06	2.17e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—PIK3R1—type 2 diabetes mellitus	2.6e-06	2.17e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.59e-06	2.16e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.58e-06	2.15e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.58e-06	2.15e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.57e-06	2.14e-05	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—INS—type 2 diabetes mellitus	2.57e-06	2.14e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—AGT—type 2 diabetes mellitus	2.57e-06	2.14e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.56e-06	2.13e-05	CbGpPWpGaD
Flunarizine—CALM3—Hemostasis—AKT1—type 2 diabetes mellitus	2.55e-06	2.13e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.54e-06	2.12e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.54e-06	2.12e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	2.11e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	2.11e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.52e-06	2.1e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—APOE—type 2 diabetes mellitus	2.51e-06	2.09e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—LEP—type 2 diabetes mellitus	2.51e-06	2.09e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.51e-06	2.09e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.5e-06	2.08e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.5e-06	2.08e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.5e-06	2.08e-05	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—IL6—type 2 diabetes mellitus	2.49e-06	2.08e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.49e-06	2.08e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.49e-06	2.08e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.49e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.48e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.48e-06	2.07e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.48e-06	2.06e-05	CbGpPWpGaD
Flunarizine—CALM2—Hemostasis—AKT1—type 2 diabetes mellitus	2.47e-06	2.06e-05	CbGpPWpGaD
Flunarizine—CALM1—Hemostasis—AKT1—type 2 diabetes mellitus	2.47e-06	2.06e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—PTGS2—type 2 diabetes mellitus	2.46e-06	2.05e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.44e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.44e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.43e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.43e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.43e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.43e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.43e-06	2.03e-05	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.42e-06	2.02e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.41e-06	2.01e-05	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—IL6—type 2 diabetes mellitus	2.41e-06	2.01e-05	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—IL6—type 2 diabetes mellitus	2.41e-06	2.01e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.4e-06	2e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.4e-06	2e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.4e-06	2e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.38e-06	1.99e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.38e-06	1.99e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.38e-06	1.98e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—PTGS2—type 2 diabetes mellitus	2.38e-06	1.98e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—PTGS2—type 2 diabetes mellitus	2.38e-06	1.98e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.37e-06	1.98e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.37e-06	1.98e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.37e-06	1.97e-05	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—ALB—type 2 diabetes mellitus	2.36e-06	1.96e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.34e-06	1.95e-05	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.31e-06	1.93e-05	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.31e-06	1.93e-05	CbGpPWpGaD
Flunarizine—CALM3—Immune System—NFKB1—type 2 diabetes mellitus	2.31e-06	1.93e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	1.92e-05	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—AKT1—type 2 diabetes mellitus	2.3e-06	1.92e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.29e-06	1.91e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.29e-06	1.91e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.29e-06	1.9e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	1.9e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	1.9e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.27e-06	1.89e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.26e-06	1.89e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.26e-06	1.89e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.26e-06	1.88e-05	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	1.88e-05	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	1.88e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.24e-06	1.87e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.24e-06	1.87e-05	CbGpPWpGaD
Flunarizine—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	2.24e-06	1.86e-05	CbGpPWpGaD
Flunarizine—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	2.24e-06	1.86e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.23e-06	1.86e-05	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	2.22e-06	1.85e-05	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	2.22e-06	1.85e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.21e-06	1.84e-05	CbGpPWpGaD
Flunarizine—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.21e-06	1.84e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.19e-06	1.83e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	1.82e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	1.82e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	1.82e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	1.82e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.17e-06	1.81e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.17e-06	1.81e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.17e-06	1.81e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.17e-06	1.81e-05	CbGpPWpGaD
Flunarizine—CALM3—Immune System—SRC—type 2 diabetes mellitus	2.16e-06	1.8e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	1.79e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.15e-06	1.79e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	1.79e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.14e-06	1.78e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.14e-06	1.78e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.14e-06	1.78e-05	CbGpPWpGaD
Flunarizine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.14e-06	1.78e-05	CbGpPWpGaD
Flunarizine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.14e-06	1.78e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.13e-06	1.78e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.13e-06	1.77e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.12e-06	1.77e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.12e-06	1.77e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.12e-06	1.76e-05	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.12e-06	1.76e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.11e-06	1.76e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.1e-06	1.75e-05	CbGpPWpGaD
Flunarizine—CALM2—Immune System—SRC—type 2 diabetes mellitus	2.08e-06	1.74e-05	CbGpPWpGaD
Flunarizine—CALM1—Immune System—SRC—type 2 diabetes mellitus	2.08e-06	1.74e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.08e-06	1.73e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.08e-06	1.73e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.08e-06	1.73e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.08e-06	1.73e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.07e-06	1.72e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.06e-06	1.72e-05	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	1.72e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.04e-06	1.7e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.04e-06	1.7e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.04e-06	1.7e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.01e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.01e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.01e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.01e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2e-06	1.67e-05	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	1.66e-05	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	1.66e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—SRC—type 2 diabetes mellitus	1.99e-06	1.66e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.97e-06	1.64e-05	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-06	1.63e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.95e-06	1.63e-05	CbGpPWpGaD
Flunarizine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.94e-06	1.62e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—SRC—type 2 diabetes mellitus	1.92e-06	1.6e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—SRC—type 2 diabetes mellitus	1.92e-06	1.6e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.92e-06	1.6e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.92e-06	1.6e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.91e-06	1.59e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.91e-06	1.59e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.91e-06	1.59e-05	CbGpPWpGaD
Flunarizine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	1.89e-06	1.57e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.88e-06	1.57e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.88e-06	1.57e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	1.56e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.86e-06	1.55e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.85e-06	1.54e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.83e-06	1.53e-05	CbGpPWpGaD
Flunarizine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	1.83e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	1.83e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.83e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.82e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.82e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.82e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.82e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.82e-06	1.52e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.82e-06	1.51e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.82e-06	1.51e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.8e-06	1.5e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.8e-06	1.5e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	1.78e-06	1.48e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.77e-06	1.48e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.76e-06	1.47e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—EGFR—type 2 diabetes mellitus	1.74e-06	1.45e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	1.72e-06	1.43e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	1.72e-06	1.43e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-06	1.43e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-06	1.43e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—EGFR—type 2 diabetes mellitus	1.69e-06	1.41e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—EGFR—type 2 diabetes mellitus	1.69e-06	1.41e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	1.4e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.67e-06	1.4e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.67e-06	1.39e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.63e-06	1.36e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	1.34e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	1.34e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.6e-06	1.33e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.59e-06	1.33e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.59e-06	1.33e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.59e-06	1.32e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.58e-06	1.32e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.55e-06	1.29e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-06	1.29e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-06	1.29e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-06	1.28e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-06	1.28e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.51e-06	1.26e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.5e-06	1.25e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.5e-06	1.25e-05	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1.23e-05	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.47e-06	1.22e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.47e-06	1.22e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.46e-06	1.22e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.46e-06	1.22e-05	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.46e-06	1.21e-05	CbGpPWpGaD
Flunarizine—CALM3—Immune System—IL6—type 2 diabetes mellitus	1.45e-06	1.21e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-06	1.2e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-06	1.2e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.42e-06	1.19e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-06	1.18e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-06	1.18e-05	CbGpPWpGaD
Flunarizine—CALM2—Immune System—IL6—type 2 diabetes mellitus	1.4e-06	1.17e-05	CbGpPWpGaD
Flunarizine—CALM1—Immune System—IL6—type 2 diabetes mellitus	1.4e-06	1.17e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-06	1.16e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-06	1.14e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-06	1.14e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.36e-06	1.13e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-06	1.12e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-06	1.12e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—IL6—type 2 diabetes mellitus	1.34e-06	1.12e-05	CbGpPWpGaD
Flunarizine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	1.34e-06	1.12e-05	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	1.1e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	1.09e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	1.09e-05	CbGpPWpGaD
Flunarizine—CALM2—Disease—IL6—type 2 diabetes mellitus	1.3e-06	1.08e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—IL6—type 2 diabetes mellitus	1.3e-06	1.08e-05	CbGpPWpGaD
Flunarizine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	1.3e-06	1.08e-05	CbGpPWpGaD
Flunarizine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	1.3e-06	1.08e-05	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.25e-06	1.04e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.25e-06	1.04e-05	CbGpPWpGaD
Flunarizine—CALM3—Disease—AKT1—type 2 diabetes mellitus	1.24e-06	1.03e-05	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-06	1.02e-05	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.2e-06	1e-05	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.2e-06	1e-05	CbGpPWpGaD
Flunarizine—CALM1—Disease—AKT1—type 2 diabetes mellitus	1.2e-06	9.96e-06	CbGpPWpGaD
Flunarizine—CALM2—Disease—AKT1—type 2 diabetes mellitus	1.2e-06	9.96e-06	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	9.84e-06	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	9.84e-06	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.13e-06	9.4e-06	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	8.86e-06	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	8.67e-06	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	8.63e-06	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	8.34e-06	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	8.34e-06	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	9.83e-07	8.18e-06	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	9.39e-07	7.82e-06	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.08e-07	7.56e-06	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.08e-07	7.56e-06	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.66e-07	7.21e-06	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.38e-07	6.98e-06	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.38e-07	6.98e-06	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.4e-07	6.16e-06	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.33e-07	6.11e-06	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.26e-07	5.22e-06	CbGpPWpGaD
